Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-12-31

FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental NDA for Actonel (risendronate sodium) to update the labeling, potentially adding or revising indications and dosing informa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actonel (risedronate)

Snippet

SUPPL AP for ACTONEL (RISEDRONATE SODIUM)